4qf8 Citations

Structures and binding studies of the complexes of phospholipase A2 with five inhibitors.

Biochim Biophys Acta 1854 269-77 (2015)
Related entries: 4qem, 4qer, 4qf7, 4qgd

Cited: 10 times
EuropePMC logo PMID: 25541253

Abstract

Phospholipase A2 (PLA2) catalyzes the hydrolysis of phospholipids into arachidonic acid and lysophospholipids. Arachidonic acid is used as a substrate in the next step of the multistep pathway leading to the production of eicosanoids. The eicosanoids, in extremely low concentrations, are required in a number of physiological processes. However, the increase in their concentrations above the essential physiological requirements leads to various inflammatory conditions. In order to prevent the unwanted rise in the concentrations of eicosanoids, the actions of PLA2 and other enzymes of the pathway need to be blocked. We report here the structures of five complexes of group IIA PLA2 from Daboia russelli pulchella with tightly binding inhibitors, (i) p-coumaric acid, (ii) resveratrol, (iii) spermidine, (iv) corticosterone and (v) gramine derivative. The binding studies using fluorescence spectroscopy and surface plasmon resonance techniques for the interactions of PLA2 with the above five compounds showed high binding affinities with values of dissociation constants (KD) ranging from 3.7×10(-8) M to 2.1×10(-9) M. The structure determinations of the complexes of PLA2 with the above five compounds showed that all the compounds bound to PLA2 in the substrate binding cleft. The protein residues that contributed to the interactions with these compounds included Leu2, Leu3, Phe5, Gly6, Ile9, Ala18, Ile19, Trp22, Ser23, Cys29, Gly30, Cys45, His48, Asp49 and Phe106. The positions of side chains of several residues including Leu2, Leu3, Ile19, Trp31, Lys69, Ser70 and Arg72 got significantly shifted while the positions of active site residues, His48, Asp49, Tyr52 and Asp99 were unperturbed.

Articles - 4qf8 mentioned but not cited (1)



Reviews citing this publication (5)

  1. Resveratrol: How Much Wine Do You Have to Drink to Stay Healthy? Weiskirchen S, Weiskirchen R. Adv Nutr 7 706-718 (2016)
  2. Polyphenols in the treatment of autoimmune diseases. Khan H, Sureda A, Belwal T, Çetinkaya S, Süntar İ, Tejada S, Devkota HP, Ullah H, Ullah H, Aschner M. Autoimmun Rev 18 647-657 (2019)
  3. Polypharmacology or Promiscuity? Structural Interactions of Resveratrol With Its Bandwagon of Targets. Saqib U, Kelley TT, Panguluri SK, Liu D, Savai R, Baig MS, Schürer SC. Front Pharmacol 9 1201 (2018)
  4. Perspective on the Therapeutics of Anti-Snake Venom. Gómez-Betancur I, Gogineni V, Salazar-Ospina A, León F. Molecules 24 E3276 (2019)
  5. Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations. Adrião AAX, Dos Santos AO, de Lima EJSP, Maciel JB, Paz WHP, da Silva FMA, Pucca MB, Moura-da-Silva AM, Monteiro WM, Sartim MA, Koolen HHF. Front Immunol 13 842576 (2022)

Articles citing this publication (4)

  1. Good vibrations: Assessing the stability of snake venom composition after researcher-induced disturbance in the laboratory. Claunch NM, Holding ML, Escallón C, Vernasco B, Moore IT, Taylor EN. Toxicon 133 127-135 (2017)
  2. A novel GPR55-mediated satiety signal in the oval Bed Nucleus of the Stria Terminalis. Hawken ER, Normandeau CP, Gardner Gregory J, Cécyre B, Bouchard JF, Mackie K, Dumont ÉC. Neuropsychopharmacology 44 1274-1283 (2019)
  3. Anti-5'-Nucleotidases (5'-ND) and Acetylcholinesterase (AChE) Activities of Medicinal Plants to Combat Echis carinatus Venom-Induced Toxicities. Aslam N, Fatima S, Khalid S, Hussain S, Qayum M, Afzal K, Asad MHHB. Biomed Res Int 2021 6631042 (2021)
  4. Crystal structure of death-associated protein kinase 1 in complex with the dietary compound resveratrol. Yokoyama T, Suzuki R, Mizuguchi M. IUCrJ 8 131-138 (2021)